Your browser doesn't support javascript.
loading
Prognostic impact of RAS-pathway mutations in patients with myelofibrosis.
Santos, Fabio P S; Getta, Bartlomiej; Masarova, Lucia; Famulare, Christopher; Schulman, Jessica; Datoguia, Tarcila S; Puga, Renato D; Alves Paiva, Raquel de Melo; Arcila, Maria E; Hamerschlak, Nelson; Kantarjian, Hagop M; Levine, Ross L; Campregher, Paulo Vidal; Rampal, Raajit K; Verstovsek, Srdan.
Afiliação
  • Santos FPS; Centro de Hematologia e Oncologia Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil. santos.fabio2@einstein.br.
  • Getta B; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Famulare C; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Schulman J; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Datoguia TS; Centro de Hematologia e Oncologia Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Puga RD; Centro de Hematologia e Oncologia Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Alves Paiva RM; Centro de Hematologia e Oncologia Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Arcila ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hamerschlak N; Centro de Hematologia e Oncologia Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Levine RL; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Campregher PV; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rampal RK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Verstovsek S; Centro de Hematologia e Oncologia Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Leukemia ; 34(3): 799-810, 2020 03.
Article em En | MEDLINE | ID: mdl-31628430
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes ras / Mielofibrose Primária / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes ras / Mielofibrose Primária / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil